CagriSema's imminent approval will create true competition at the top of the obesity treatment landscape
Conagra Brands began marketing some of its high-protein or nutrient-packed items as GLP-1-friendly. But it has been difficult for pharmacies and drug developers to meet the high demand for the medications and keep them stocked

Research findings reveal substantially elevated gastrointestinal risks demonstrating: Pancreatitis Risk : Patients using GLP-1 agonists showed a 9.09-fold increased risk (adjusted hazard ratio) for developing pancreatitis compared to those using alternative weight loss medications Gastroparesis Development : The study revealed a 3.67-fold increased risk for gastroparesis, often occurring secondary to pancreatic inflammation Bowel Obstruction : A 4.22-fold increased risk for intestinal blockages was documented, frequently accompanying severe gastroparesis cases FDA Adverse Event Reports : Analysis of the FDAs FAERS database through 2024 shows over 900 reported cases of pancreatitis specifically linked to semaglutide use Post-Marketing Surveillance : Real-world data from 2023-2024 indicates that serious gastrointestinal events occur more frequently than initially reported in clinical trials When pancreatitis develops, the inflamed pancreas releases numerous enzymes, toxic substances, and vasoactive compounds including inflammatory cytokines that can damage the autonomic nervous system controlling gastric function

Read More Turmeric has been used for medicinal purposes for centuries
And an in-use pen can remain at room temperature for up to 56 days, which covers nearly any trip length without needing to maintain cold chain
27 Several observational studies have explored the mechanism by which metabolic syndrome relates to male reproductive health